Description

Buy Opdivo (Nivolumab) For Sale USA

Opdivo (nivolumab) is a cancer medicine that is given intravenously (into a vein) that works with your immune system to interfere with the growth and spread of cancer cells in the body.

Opdivo is used alone or in combination with other medicines to treat adults with:

• advanced melanoma (a type of skin cancer);
• resectable or advanced non-small cell lung cancer (NSCLC);
• pleural mesothelioma (cancer that affects the lining of the lungs and chest wall);
• kidney cancer (renal cell carcinoma);
• classical Hodgkin lymphoma (cHL);
• squamous cell cancer of the esophagus or head and neck;
• bladder cancer (urothelial carcinoma);
• liver cancer;
• colorectal cancer; or
• cancer of the stomach and esophagus.

For some cancers, such as melanoma and colorectal cancer, Opdivo is also approved for children aged 12 years and older. See the prescribing information for a full list of indications and eligibility criteria.

Opdivo is often given when the cancer has spread to other parts of the body (metastatic), cannot be surgically removed, or has come back after prior treatment.

Opdivo is sometimes given only if laboratory testing shows specific genetic markers or DNA mutations associated with your cancer.

Opdivo belongs to the class of medicines known as checkpoint inhibitors and works by blocking the PD-1 (programmed death receptor-1) pathway to help prevent cancer cells from hiding from the immune system, boosting the immune system’s response against cancer.

Warnings

Opdivo can cause serious, sometimes life-threatening, side effects in many different parts of your body. Some side effects may need to be treated with other medicines, and your cancer treatments may be delayed.

Call your doctor at once if you have a cough, shortness of breath or other lung problems, vision changes, muscle pain or weakness, stomach pain, diarrhea, blood in your stools, little or no urinating, bruising or bleeding, dark urine (tea colored), yellowing of your skin or eyes, severe nausea or vomiting, frequent headaches, dizziness, confusion, increased thirst or urination, skin problems, numbness or tingling, feeling cold, changes in mood or behavior, decreased sex drive, increased sweating, sensitivity to light or other eye problems, skin problems, bruising, or weight gain or loss.

Problems can also happen in other organs and tissues. These are not all signs and symptoms of immune system problems that can happen with Opdivo.

• Your healthcare provider will conduct regular laboratory tests throughout your treatment.

Opdivo can cause severe infusion-related reactions. Tell your healthcare provider right away if you experience chest tightness, wheezing, shortness of breath, facial flushing, itching, hives, swelling, or any other allergic reaction. Buy Opdivo (Nivolumab) For Sale USA

Life-threatening and other serious complications can occur in people who have received an allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody, such as Opdivo.

May cause harm to an unborn baby. Females who can get pregnant should use an adequate form of contraception while being treated with Opdivo.